Operating Income (Loss) of DA32 Life Science Tech Acquisition Corp. from 30 Jun 2021 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
DA32 Life Science Tech Acquisition Corp. quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Jun 2021 to 31 Mar 2023.
  • DA32 Life Science Tech Acquisition Corp. Operating Income (Loss) for the quarter ending 31 Mar 2023 was $411,859, a 24% decline year-over-year.
  • DA32 Life Science Tech Acquisition Corp. Operating Income (Loss) for the twelve months ending 31 Mar 2023 was $1,838,613.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)

DA32 Life Science Tech Acquisition Corp. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $1,838,613 $411,859 -$78,485 -24% 01 Jan 2023 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $1,760,128 $386,759 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2023 2022 Q4
Q3 2022 $427,775 -$146,948 -52% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $612,220 -$569,556 -1335% 01 Apr 2022 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $333,374 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2021 $280,827 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $42,664 16 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2

DA32 Life Science Tech Acquisition Corp. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,760,128 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.